Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

doi:10.3748/wjg.v23.i47.8355

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 47

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11504)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

1025

WORD

332

HTML

6366

Figures (1-6)

260

Tables (1-1)

220

Sum=8203

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1278

Download

2023

Sum=3301

Dec 21, 2017 (publication date) through Dec 11, 2024

Times Cited of This Article

Times Cited (78)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Dec 21, 2017; 23(47): 8355-8366
Published online Dec 21, 2017. doi: 10.3748/wjg.v23.i47.8355

Full Size Figure Download Figure

Figure 6 Alterations in abundances of selected genera by treatment with rifaximin. Relative abundances of (A) Veillonella, (B) Streptococcus, (C) Lactobacillus, (D) Prevotella, (E) Haemophilus, (F) Megaspaera and (G) Fusobacterium. Data are means ± SD.

Citation: Kaji K, Takaya H, Saikawa S, Furukawa M, Sato S, Kawaratani H, Kitade M, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity. World J Gastroenterol 2017; 23(47): 8355-8366
URL: https://www.wjgnet.com/1007-9327/full/v23/i47/8355.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i47.8355